Search results
Immunotherapy for Cancer: What Are My Options?
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a relatively new approach to cancer treatment. It improves the body's immune system's ability to find and fight cancer. Since 2010,...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Bristol Myers' Opdivo extends survival in bladder cancer study
Reuters via AOL· 10 months agoThe drug met the dual main goals of extending overall survival and helping patients live without...
On an Immunotherapy Drug? Acetaminophen Makes It Less Effective, Research Says
Woman's World via Yahoo News· 1 year agoIf you or a loved one has cancer, you know by now that anti-cancer drugs are hard on the body. They...
Looking to the future Cancer specialists optimistic about expanded melanoma treatments
The Ledger via Yahoo News· 2 years agoThe past decade was an exciting time for patients diagnosed with advanced melanoma, the least common...
Bristol Myers' (BMY) Opdivo With Chemo Gets EC Nod for NSCLC
Zacks via Yahoo Finance· 10 months agoBristol Myers' (BMY) Opdivo, in combination with chemotherapy, gains European Commission approval...
Bristol Myers gets positive data in subcutaneous Opdivo trial
BioPharma Dive via Yahoo Finance· 3 months agoAn under-the-skin Opdivo shot produced similar results to an intravenous formulation in kidney...
Keytruda gains first approval for pre- and post-surgery use in lung cancer
BioPharma Dive via Yahoo Finance· 7 months agoThe Merck drug leads competitors Opdivo and Imfinzi into a new immunotherapy setting, which aims to...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 2 weeks agoParis-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in...